Zhenbo Hu Selected Research

CPI-0610

1/2020

Safety and Efficacy of Bromodomain and Extra-Terminal Inhibitors for the Treatment of Hematological Malignancies and Solid Tumors: A Systematic Study of Clinical Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhenbo Hu Research Topics

Disease

8	Leukemia 01/2022 - 06/2011
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2016
7	Neoplasms (Cancer) 08/2022 - 01/2011
3	Acute Promyelocytic Leukemia 01/2022 - 01/2021
2	Carcinogenesis 01/2021 - 04/2016
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2020
1	Hematologic Neoplasms (Hematological Malignancy) 01/2020
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Myeloid Leukemia (Leukemia, Myelocytic) 05/2014
1	Melanoma (Melanoma, Malignant) 07/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 02/2011

Drug/Important Bio-Agent (IBA)

4	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 01/2018
3	Histones (Histone)IBA 01/2021 - 06/2011
2	Pharmaceutical PreparationsIBA 08/2022 - 07/2012
2	LipidsIBA 08/2022 - 01/2022
2	Biological ProductsIBA 01/2022 - 04/2016
2	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2022
2	Histone DemethylasesIBA 01/2021 - 01/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2011
2	TransferasesIBA 01/2017 - 07/2012
2	Decitabine FDA Link 01/2017 - 07/2012
2	DeoxycytidineIBA 01/2017 - 07/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 07/2012
2	Co-Repressor ProteinsIBA 05/2014 - 06/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2022
1	lysophosphatidic acidIBA 08/2022
1	honokiolIBA 01/2022
1	Arsenic Trioxide (Trisenox)FDA Link 01/2021
1	Kaurane DiterpenesIBA 01/2021
1	DiterpenesIBA 01/2021
1	oridoninIBA 01/2021
1	Tadalafil (Cialis)FDA Link 01/2021
1	Lysine (L-Lysine)FDA Link 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 09/2020
1	Peptides (Polypeptides)IBA 04/2020
1	KLA peptideIBA 04/2020
1	Enhancer of Zeste Homolog 2 ProteinIBA 04/2020
1	Cell-Penetrating PeptidesIBA 04/2020
1	AZD5153IBA 01/2020
1	ODM-207IBA 01/2020
1	CPI-0610IBA 01/2020
1	INCB054329IBA 01/2020
1	molibresibIBA 01/2020
1	mivebresibIBA 01/2020
1	PLX51107IBA 01/2020
1	INCB057643IBA 01/2020
1	NucleophosminIBA 10/2018
1	mirfentanilIBA 01/2017
1	NucleosidesIBA 01/2017
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 04/2016
1	Carrier Proteins (Binding Protein)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	TetrahydrouridineIBA 07/2012
1	entinostat (MS 275)IBA 06/2011
1	Vorinostat FDA Link 06/2011
1	Tumor Biomarkers (Tumor Markers)IBA 01/2011
1	HLA-G Antigens (HLA G)IBA 01/2011
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2011

Therapy/Procedure

3	Therapeutics 01/2022 - 05/2014
2	Drug Therapy (Chemotherapy) 07/2012 - 02/2011